BRIEF-Impax signs agreements to acquire generic products from Teva, Allergan

* Expects 2016 total company revenues to increase at least 15% over full year 2015
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.